SNY FY 2014 Earnings Report — Sanofi Revenue & Financial Results | Market Cap Arena

FY 2014 Earnings

Reported December 30, 2014

Quarter Comparison

Revenue

Operating Income

Gross Margin

Net Margin

EPS (Diluted)

Free Cash Flow

Metric	FY 2014	Prior Q	FY 2013	QoQ Change	YoY Change
Revenue	$37.5B	—	$36.6B	—	2.3%
Op. Income	$7.1B	—	$5.8B	—	21.7%
Gross Margin	68.0%	—	67.1%	—	1.0pp
Net Margin	13.7%	—	11.9%	—	1.8pp
EPS (Diluted)	$1.96	—	$1.65	—	18.4%
Free Cash Flow	$7.2B	—	$6.5B	—	10.4%

Revenue Flow

Item	Amount
REVENUE	$37.5B
Cost of Revenue	$12.0B
GROSS PROFIT	$25.5B
R&D Expenses	$5.5B
Selling & Marketing	$0
General & Administrative	$0
SG&A Expenses	$9.9B
Other Expenses	$3.1B
Operating Expenses	$18.4B
Cost & Expenses	$30.4B
OPERATING INCOME	$7.1B
Interest Income	$122M
Interest Expense	$529M
Other Income/Expenses	-$536M
INCOME BEFORE TAX	$6.6B
Income Tax Expense	$1.4B
Net Income from Continuing Ops	$5.1B
Net Income from Discontinued Ops	$137M
Other Adjustments	$0
NET INCOME	$5.1B
Net Income Deductions	$0
BOTTOM LINE NET INCOME	$5.1B
D&A	$3.8B
EBIT	$7.3B
EBITDA	$11.2B
EPS	$2
EPS Diluted	$2

Income Statement

Item	Amount
REVENUE	$37.5B
Cost of Revenue	$12.0B
GROSS PROFIT	$25.5B
R&D Expenses	$5.5B
Selling & Marketing	$0
General & Administrative	$0
SG&A Expenses	$9.9B
Other Expenses	$3.1B
Operating Expenses	$18.4B
Cost & Expenses	$30.4B
OPERATING INCOME	$7.1B
Interest Income	$122M
Interest Expense	$529M
Other Income/Expenses	-$536M
INCOME BEFORE TAX	$6.6B
Income Tax Expense	$1.4B
Net Income from Continuing Ops	$5.1B
Net Income from Discontinued Ops	$137M
Other Adjustments	$0
NET INCOME	$5.1B
Net Income Deductions	$0
BOTTOM LINE NET INCOME	$5.1B
D&A	$3.8B
EBIT	$7.3B
EBITDA	$11.2B
EPS	$2
EPS Diluted	$2

Cash Flow Statement

Item	Amount
Net Income	$5.1B
Depreciation & Amortization	$4.4B
Stock-Based Compensation	$241M
Deferred Income Tax	-$1.5B
Other Non-Cash Items	-$192M
Change in Working Capital	$1.1B
OPERATING CASH FLOW	$9.0B
Capital Expenditure	-$1.8B
Acquisitions (Net)	-$2.0B
Purchases of Investments	-$669M
Sales/Maturities of Investments	$0
Other Investing Activities	$460M
NET CASH FROM INVESTING	-$4.1B
Net Debt Issuance	-$457M
Common Stock Repurchased	-$2.1B
Common Dividends Paid	-$4.3B
Other Financing Activities	$804M
NET CASH FROM FINANCING	-$6.1B
FREE CASH FLOW	$7.2B
Net Change in Cash	-$1.1B

Balance Sheet

Item	Amount
Cash & Equivalents	$8.6B
Short-Term Investments	$255M
Net Receivables	$10.6B
Inventory	$7.7B
Other Current Assets	$0
TOTAL CURRENT ASSETS	$27.4B
PP&E (Net)	$12.2B
Goodwill	$45.9B
Intangible Assets	$17.0B
Long-Term Investments	$5.7B
Tax Assets	$5.7B
Other Non-Current Assets	$81M
TOTAL NON-CURRENT ASSETS	$86.6B
TOTAL ASSETS	$114.0B
Account Payables	$4.3B
Short-Term Debt	$1.8B
Deferred Revenue	$0
Other Current Liabilities	$5.8B
TOTAL CURRENT LIABILITIES	$15.3B
Long-Term Debt	$15.5B
Deferred Revenue NC	$0
Deferred Tax Liabilities	$4.8B
Other Non-Current Liabilities	$12.5B
TOTAL NON-CURRENT LIABILITIES	$32.9B
TOTAL LIABILITIES	$48.2B
Common Stock	$3.1B
Additional Paid-In Capital	$0
Retained Earnings	$61.5B
Treasury Stock	-$813M
Accum. Other Comp. Income	$1.9B
Other Equity	$0
TOTAL STOCKHOLDERS' EQUITY	$65.7B
Minority Interest	$173M
TOTAL EQUITY	$65.9B
TOTAL LIABILITIES & EQUITY	$114.0B
Total Debt	$17.3B
Net Debt	$8.8B